Form EFFECT BriaCell Therapeutics

January 14, 2026 6:04 AM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 13, 2026 5:00 P.M.
Form: S-1
CIK: 0001610820
Company Name: BriaCell Therapeutics Corp.
File Number: 333-292388


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings